Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.

Matthay KK.

Clin Cancer Res. 2013 Jan 15;19(2):311-3. doi: 10.1158/1078-0432.CCR-12-3313. Epub 2012 Dec 3.

2.

Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.

Reynolds CP.

Curr Oncol Rep. 2000 Nov;2(6):511-8. Review.

PMID:
11122886
3.

Practical implications for the administration of 13-cis retinoic acid in pediatric oncology.

Bauters TG, Laureys G, Van de Velde V, Benoit Y, Robays H.

Int J Clin Pharm. 2011 Aug;33(4):597-8. doi: 10.1007/s11096-011-9519-9. Review.

PMID:
21544558
4.

13-cis retinoic acid and isomerisation in paediatric oncology--is changing shape the key to success?

Armstrong JL, Redfern CP, Veal GJ.

Biochem Pharmacol. 2005 May 1;69(9):1299-306. Review.

PMID:
15826600
5.

Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.

Masetti R, Biagi C, Zama D, Vendemini F, Martoni A, Morello W, Gasperini P, Pession A.

Adv Ther. 2012 Sep;29(9):747-62. doi: 10.1007/s12325-012-0047-3. Epub 2012 Aug 28. Review.

PMID:
22941525
6.

Retinoid therapy of childhood cancer.

Reynolds CP, Lemons RS.

Hematol Oncol Clin North Am. 2001 Oct;15(5):867-910. Review.

PMID:
11765378
7.

Retinoid therapy of high-risk neuroblastoma.

Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ.

Cancer Lett. 2003 Jul 18;197(1-2):185-92. Review.

PMID:
12880980
8.

Oral isotretinoin. Where now, where next?

Saurat JH.

Dermatology. 1997;195 Suppl 1:1-3; discussion 38-40. Review.

PMID:
9310738
9.
10.

Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.

Jones E, Korzenko A, Kriegel D.

J Drugs Dermatol. 2004 Sep-Oct;3(5):498-502. Review.

PMID:
15552602

Supplemental Content

Support Center